Cargando…
Proactive strategies to optimize engagement of Black, Hispanic/Latinx, transgender, and nonbinary individuals in a trial of a novel agent for HIV pre-exposure prophylaxis (PrEP)
INTRODUCTION: Black and Hispanic/Latinx cisgender men who have sex with men (MSM), transgender women, transgender men, and gender nonbinary (TGNB) individuals have been historically underrepresented in HIV pre-exposure prophylaxis (PrEP) clinical trials. There is an urgent need for ongoing engagemen...
Autores principales: | Cespedes, Michelle, Das, Moupali, Hojilla, J. Carlo, Blumenthal, Jill, Mounzer, Karam, Ramgopal, Moti, Hodge, Theo, Torres, Thiago S., Peterson, Charles, Shibase, Senzokuhle, Elliott, Ayana, Demidont, A. C., Callaghan, Larkin, Watson, C. Chauncey, Carter, Christoph, Kintu, Alex, Baeten, Jared M., Ogbuagu, Onyema |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9165827/ https://www.ncbi.nlm.nih.gov/pubmed/35657826 http://dx.doi.org/10.1371/journal.pone.0267780 |
Ejemplares similares
-
848. Approaches to Optimize Recruitment of Historically Underrepresented Black and Hispanic/LatinX MSM, Transgender, and Gender Non-binary Individuals into the Lenacapavir for PrEP (PURPOSE 2) Trial
por: Cespedes, Michelle, et al.
Publicado: (2021) -
1556. Increase in New HIV Diagnoses Following Decrease in Use of Pre-Exposure Prophylaxis (PrEP) During the COVID-19 Pandemic
por: Tao, Li, et al.
Publicado: (2023) -
1962. Renal Outcomes for Participants Taking F/TAF vs. F/TDF for HIV PrEP in the DISCOVER Trial
por: Mills, Anthony, et al.
Publicado: (2019) -
1288. Bone Safety Outcomes with F/TAF vs. F/TDF for PrEP in the DISCOVER Trial
por: Wohl, David, et al.
Publicado: (2019) -
Supporting Transgender and Nonbinary Residents
por: Weinand, Jamie D., et al.
Publicado: (2019)